Please assess the completion status of the following clinical trial:

Trial Title: Role of Glycation and Inflammation in Acute Ischemic Heart Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* hospitalization for first myocardial infarction (STEMI or NSTEMI)~* age between 18 and 80~Exclusion Criteria:~* uncompensated T2DM (HbA1c \>53mmol/mol)~* use of anti-CD20 treatment~* chronic anti-inflammatory treatment for autoimmune disease (i.e. DMARDs, high dose FANS, cortisonic drugs)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- First Ischemic Cardiac Event (Type: None): Measurement of BAFF and MGO at hospitalization (before reperfusion) and after 3 months during follow-up

Based on this trial design, predict the completion outcome and termination type (if applicable).